Medical weight loss is a prescriber-supervised obesity treatment that can include FDA-approved GLP-1 medicines such as tirzepatide or semaglutide.
Two counties, nearly three million people
Long Island's two counties had 2,945,029 residents in July 2025: 1,398,939 in Nassau and 1,546,090 in Suffolk [6][7]. CDC PLACES estimates adult obesity at 28.4% in Nassau and 29.7% in Suffolk in 2023, with diagnosed diabetes at about 10% in both [4][5]. There is no single Long Island figure, so we show both counties.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Long Island, from $300 a month.
This labeled spot is sold to local practices. It is advertising, not an endorsement.
Medicine prices, not clinic prices
| Drug | Monthly price | Where | Source |
|---|---|---|---|
| Wegovy pill | $149 to $299 | NovoCare or retail pharmacy with offer | [1] |
| Wegovy pen | $349 | NovoCare or retail pharmacy with offer | [1] |
| Zepbound | $299 to $449 | LillyDirect delivery or Walmart pickup | [2] |
Readers looking for tirzepatide on Long Island can start with tirzepatide cost and Zepbound cost. The GLP-1 cost comparison covers everything else.
Hospital programs
We could not confirm the details of any Long Island hospital weight management program during this update, so we do not list one. Ask your primary care doctor for a referral to obesity medicine or endocrinology, and ask the program three things: whether it prescribes brand GLP-1s, what a self-pay visit costs, and whether you can fill the drug through a manufacturer cash program.
Rules that protect New York patients
New York treats paying or receiving fees for patient referrals, and improper fee splitting, as professional misconduct for licensees [9]. Physician licenses are issued through the State Education Department's Office of the Professions, where you can look up a prescriber [8]. Be cautious with any program that calls compounded semaglutide or tirzepatide generic or the same as a brand. Compounded versions are not FDA-approved, and FDA does not review them for safety, effectiveness or quality [10].
Coverage options
- Medicaid: New York does not cover GLP-1s for obesity [3].
- Medicare Part D: the GLP-1 Bridge charges $50 a month for eligible members from July 1, 2026 through December 31, 2027 [11].
- Commercial plans: if Zepbound is covered, Lilly's savings card can cut the cost to $25; if it is not, the card brings the KwikPen to $299 to $449 [12].
Warning signs
Stop and call your prescriber for severe stomach pain that will not go away, which can be pancreatitis, or for swelling, rash or trouble breathing. If you also use insulin or a sulfonylurea, watch for low blood sugar. GLP-1 drugs carry a boxed warning for thyroid C-cell tumors in animals [13][14]. Ask about pregnancy guidance on the label. Call 911 in an emergency.
More options
Nearby pages: New York City, New Jersey and Boston. Telehealth programs are compared in online GLP-1 programs. See the weight loss hub and how to find a clinic.
Questions people ask
How much is medical weight loss on Long Island?
How much is tirzepatide on Long Island?
Brand Zepbound is $299 to $449 a month through LillyDirect, depending on dose [2].
What are obesity rates in Nassau and Suffolk?
Does New York Medicaid cover Wegovy or Zepbound for weight loss?
No. KFF's January 2026 review does not count New York among states covering GLP-1s for obesity [3].
How do I check a Long Island doctor's license?
Use the New York State Education Department Office of the Professions license lookup [8].
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide and semaglutide are not FDA-approved, and FDA does not review them for safety, effectiveness or quality [10].
Sources
14 cited
- Wegovy self-pay offer. Novo Nordisk (NovoCare), accessed 2026-10-17.
- Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- PLACES county estimates: Nassau County, NY. CDC PLACES (2025 release, BRFSS 2023), 2025 release.
- PLACES county estimates: Suffolk County, NY. CDC PLACES (2025 release, BRFSS 2023), 2025 release.
- QuickFacts: Nassau County, New York. U.S. Census Bureau, V2025 estimates, accessed 2026-10-17.
- QuickFacts: Suffolk County, New York. U.S. Census Bureau, V2025 estimates, accessed 2026-10-17.
- New York State Board for Medicine. NYS Education Department, Office of the Professions, accessed 2026-10-17.
- N.Y. Education Law 6530: professional misconduct. New York State Senate, accessed 2026-10-17.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- Weight loss drugs coverage. Medicare.gov, accessed 2026-10-17.
- Zepbound coverage and savings. Eli Lilly and Company, accessed 2026-10-17.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration, Apr 2026.
- Wegovy label. DailyMed, NLM, Jun 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.